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Background: Most studies investigating the impact of completeness of revascularization in patients with multivessel coronary disease (MVD) are 
underpowered to detect a mortality difference.
Methods: We used MEDLINE, Cochrane and EMBASE (through June 2009) to conduct a comprehensive search for studies comparing mortality 
among patients with complete revascularization (CR) vs. incomplete revascularization (IR) in stent era. US Preventive Services Task Force criteria 
were used to evaluate study quality. Analyses were performed using Comprehensive Meta-Analysis software (Biostat, NJ).
Results: Out of 1,634 studies initially screened, 9 (1 clinical trial and 8 observational) studies met our selection criteria. Compared to IR, patients 
undergoing CR had significantly lower risk of mortality (summary risk ratio: 0.77; 95% Confidence interval: 0.68-0.86; p = 0.003) during an average 
(weighted mean) follow up of 25.0 months. In sensitivity analysis, the results were unchanged when we excluded studies reporting unadjusted 
outcomes (n=4), those restricted to diabetics (n=2), those restricted to drug eluting stent use (n=1), or those reporting cardiac mortality only (n=1). 
We did not observe any significant heterogeneity across these studies (Q statistic = 10.99 [8 d.f.], p = 0.202, I2 = 27.2%). There was no evidence of 
publication bias.
Conclusion: In patients with MVD, CR is associated with lower mortality than IR. Further study is warranted to definitively determine the role of CR 
on clinical outcomes.
